Zobrazeno 1 - 10
of 547
pro vyhledávání: '"L, Ose"'
Publikováno v:
Journal of Lipid Research, Vol 38, Iss 1, Pp 121-131 (1997)
We studied a Norwegian patient and his family, who presented with low HDL-cholesterol. DNA sequence analysis of the apoA-I gene revealed heterozygosity for a mutation in the apoA-I gene that causes a leucine for arginine replacement at residue 160. C
Externí odkaz:
https://doaj.org/article/21d351f8e7fd480c9d5d730d9ed5e610
Publikováno v:
Journal of Lipid Research, Vol 37, Iss 7, Pp 1591-1600 (1996)
Homocysteine is an independent risk factor for cardiovascular diseases. The mechanisms by which elevated plasma concentrations of homocysteine are related to the pathogenesis of atherosclerosis are not fully understood. To examine whether homocystein
Externí odkaz:
https://doaj.org/article/90e9f6a6921a43f5be1f43a626b5dbba
Publikováno v:
Archives of Disease in Childhood. 97:272-276
Different screening strategies are currently recommended to identify children with (familial) hypercholesterolaemia in order to initiate early lipid management. However, these strategies are characterised to date by low adherence by the medical commu
Autor:
Thomas Musliner, L. Ose, Amy O. Johnson-Levonas, Amish P. Shah, Diane Tribble, J. Lin, Robert Reyes
Publikováno v:
International Journal of Clinical Practice. 61:1469-1480
The objective of this study was to compare the efficacy and safety profile of ezetimibe/simvastatin (EZE/SIMVA) tablet and SIMVA monotherapy. This was an extension study of a randomised, double-blind, placebo-controlled study in patients with primary
Publikováno v:
Acta Paediatrica. 89:1490-1492
Publikováno v:
Atherosclerosis. 241:e113-e114
Autor:
P. Pfister, Jean Dallongeville, L. Ose, Patrick Duriez, E. Hagen, J.M. Bard, Jean-Charles Fruchart
Publikováno v:
Metabolism. 44:1447-1454
In a double-blind, parallel-group, randomized study, the effects of fluvastatin (FLUV) 20 and 40 mg/d on lipoprotein particle levels were compared with those of cholestyramine (CME) 16 g/d. Lipoparticles were defined by apolipoprotein composition as
Publikováno v:
Archives of Disease in Childhood, 97(3), 272-276. (2012).
Archives of Disease in Childhood, 97(3), 272-276. London, United Kingdom: British Medical Association (2011).
Archives of Disease in Childhood, 97(3), 272-276. London, United Kingdom: British Medical Association (2011).
Different screening strategies are currently recommended to identify children with (familial) hypercholesterolaemia in order to initiate early lipid management. However, these strategies are characterised to date by low adherence by the medical commu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8152e63f495fdaa7bde606de0fe52d71
http://orbilu.uni.lu/handle/10993/27176
http://orbilu.uni.lu/handle/10993/27176
Publikováno v:
Genome Research. 3:159-162
We have performed analyses of single-strand conformation polymorphisms (SSCP) of the promoter region and the translated parts of the 18 exons of the low-density lipoprotein receptor (LDLR) gene. DNA from 20 unrelated familial hypercholesterolemia (FH
Autor:
Henrik Lambrecht Lund, E. Haug, A. Tollefsrud, Hallgeir Rui, J Norseth, L. Ose, L. Viksmoen, K. Purvis
Publikováno v:
European Journal of Clinical Pharmacology. 42:61-64
The effects of simvastatin 40 mg per day for 14 weeks on the pituitary-testis axis of 19 men with familial hypercholesterolaemia have been examined in a single-blind study. Simvastatin significantly reduced serum low density lipoprotein (LDL) cholest